Equities

Hetzer Medical Indonesia Tbk PT

MEDS:JKT

Hetzer Medical Indonesia Tbk PT

Actions
Health CareMedical Equipment and Services
  • Price (IDR)50.00
  • Today's Change0.00 / 0.00%
  • Shares traded25.00k
  • 1 Year change-41.86%
  • Beta--
Data delayed at least 10 minutes, as of Jul 26 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Hetzer Medical Indonesia Tbk is an Indonesia-based company, which is engaged in manufacturing and distributing masks for everyday use. The Company also produces and distributes hand sanitizers. It manufactures masks using an advanced technology. It distributes its products under Evo Plusmed brand. Evo Plusmed manufactures masks with four-dimensional (4D) designs in Indonesia. The Company's products include Evo Surgical Mask 3 Ply, Evo Plusmed 4D Color Edition, Evo Plusmed 4D Super Edition, Evo Plusmed 4D Special Edition, Evo Plusmed 4D Mask 5 Ply, Evo Mask Hijab Series, Evo Mask For Kids, Evo Antiseptic Handrub and Evo Plusmed Spark Edition. The Company's factory is located in Cimahi Bandung.

  • Revenue in IDR (TTM)20.90bn
  • Net income in IDR834.41m
  • Incorporated--
  • Employees24.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Opyl Ltd6.49bn-25.41bn54.64bn3.00------8.42-0.0235-0.02350.0059-0.00050.8679--39.04---339.72-146.86---268.70-----391.44-233.61---6.03-----31.539.4617.22------
Osteopore Ltd23.66bn-51.98bn62.54bn----6.81--2.64-0.0901-0.09010.04150.00750.63862.083.23---140.31---387.70--73.78---219.71--0.6869-448.580.7165--31.02---16.13------
Hokkaido Shika Sangyo Co Ltd512.26bn6.34bn67.57bn56.00----9.020.131912.4612.461,007.11142.393.6429.179.3386,323,620.004.501.888.303.2715.3214.601.240.50651.45798.390.0955.004.922.4994.6821.0730.45--
AJJ Medtech Holdings Ltd19.60bn-31.05bn72.97bn--------3.72-0.0027-0.00270.0017-0.00140.4971.222.04---78.72-27.83-233.93-35.1843.28---158.39-346.420.3731-42.441.82--170.9716.9630.94------
Bluechiip Ltd7.69bn-62.41bn75.66bn7.00--4.25--9.84-0.0068-0.00680.00080.00140.14810.12070.7382---120.26-50.46-305.73-61.9864.1760.32-812.09-605.140.265-58.500.2676---1.3210.26-64.78--9.49--
Visioneering Technologies Inc141.47bn-56.31bn76.33bn----0.7732--0.5395-0.156-0.1560.38840.16811.041.9510.25---41.20-76.38-50.73-97.7054.9044.90-39.80-98.702.85--0.00--19.0121.3641.05------
Hetzer Medical Indonesia Tbk PT20.90bn834.41m78.13bn24.00125.341.2715.903.740.39890.398912.8039.320.28010.7215.89870,889,300.001.12--1.25--63.21--3.99--1.753.530.0981---39.79---1,606.14------
Global Health Limited92.56bn-69.04bn86.70bn49.00------0.9367-0.1116-0.11160.1495-0.04741.63--20.58---121.53-31.61-970.81-80.8886.6776.70-74.59-36.02---30.84----19.608.60-293.08---13.54--
Truscreen Group Ltd20.25bn-19.70bn95.55bn----3.08--4.72-0.0048-0.00480.0050.00590.56212.6919.30---54.68-58.06-70.20-65.7832.8230.62-97.28-267.254.60--0.00--26.782.5014.63------
Biolidics Ltd3.30bn-35.26bn99.43bn15.00------30.12-0.0045-0.00450.0004-0.00230.0991.191.1118,133.33-105.67-51.21---69.1957.7241.13-1,068.02-165.860.239-31.02-----47.170.73273.46------
Data as of Jul 26 2024. Currency figures normalised to Hetzer Medical Indonesia Tbk PT's reporting currency: Indonesian Rupiah IDR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.